| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF2754-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB18061-SP | |||
| Carrier Free | FAB18061U-100UG | |||
| Carrier Free | FAB18061G-100UG | |||
| Carrier Free | FAB18061T-100UG | |||
| Carrier Free | FAB18061V-100UG | |||
| Carrier Free | FAB18061S-100UG | |||
| Carrier Free | FAB18061N-100UG | |||
| Carrier Free | FAB18061R-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-11729-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-64329-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-90707-50ul | |||
![Immunohistochemistry-Paraffin: ILT5/CD85a/LILRB3 Antibody (MM0413-9S32) [NBP2-11729] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-11729. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/ILT5-CD85a-LILRB3-Antibody-MM0413-9S32-Immunohistochemistry-Paraffin-NBP2-11729-img0001.jpg "Immunohistochemistry-Paraffin: ILT5/CD85a/LILRB3 Antibody (MM0413-9S32) [NBP2-11729] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-11729. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.")
![Flow Cytometry: ILT5/CD85a/LILRB3 Antibody (MM0413-9S32) [NBP2-11729] - Analysis using Allophycocyanin conjugate of NBP2-11729. A cell surface stain was performed on hPBMCs with ILT5 antibody (MM0413-9S32) NBP2-11729 (top image) and a matched isotype control NBP2-27287 (bottom image). Cells were incubated in an antibody dilution of 1:200 for 20 minutes at room temperature. Both antibodies were conjugated to APC. A co-stain was performed using CD14 antibody (M5E2) NB100-77758PE.](http://images.novusbio.com/fullsize/ILT5-CD85a-LILRB3-Antibody-MM0413-9S32-Flow-Cytometry-NBP2-11729-img0002.jpg)
![Flow Cytometry: ILT5/CD85a/LILRB3 Antibody (4F9) [NB100-64329] - Figure A. StarBright Blue 580 conjugated Mouse anti Human CD19 and Alexa Fluor 647 conjugated Mouse IgG1 isotype control. Figure B. StarBright Blue 580 conjugated Mouse anti Human CD1 and Alexa Fluor 647 conjugated Mouse anti Human CD85j. All experiments performed on red cell lysed human blood gated on single cell lymphocytes, in the presence of 10% human serum. Data acquired on the ZE5 Cell Analyzer.](http://images.novusbio.com/fullsize/nb100-64329_mouse-monoclonal-ilt5-cd85a-lilrb3-antibody-4f9-23120252359811.png "Flow Cytometry: ILT5/CD85a/LILRB3 Antibody (4F9) [NB100-64329] - Figure A. StarBright Blue 580 conjugated Mouse anti Human CD19 and Alexa Fluor 647 conjugated Mouse IgG1 isotype control. Figure B. StarBright Blue 580 conjugated Mouse anti Human CD1 and Alexa Fluor 647 conjugated Mouse anti Human CD85j. All experiments performed on red cell lysed human blood gated on single cell lymphocytes, in the presence of 10% human serum. Data acquired on the ZE5 Cell Analyzer.")
![Flow Cytometry: ILT5/CD85a/LILRB3 Antibody (058) [NBP2-90707] - Flow cytometric analysis of Mouse LILRB3(CD85a) expression on BABL/c splenocytes. Cells were stained with purified anti-Mouse LILRB3(CD85a), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.](http://images.novusbio.com/fullsize/ILT5-CD85a-LILRB3-Antibody-058-Flow-Cytometry-NBP2-90707-img0002.jpg "Flow Cytometry: ILT5/CD85a/LILRB3 Antibody (058) [NBP2-90707] - Flow cytometric analysis of Mouse LILRB3(CD85a) expression on BABL/c splenocytes. Cells were stained with purified anti-Mouse LILRB3(CD85a), then a FITC-conjugated second step antibody. The fluorescence histograms were derived from gated events with the forward and side light-scatter characteristics of intact cells.")
![Immunocytochemistry/Immunofluorescence: ILT5/CD85a/LILRB3 Antibody (058) [NBP2-90707] - Immunofluorescence staining of mouse LILRB3 in mouse splenocytes. Cells were fixed with 4% PFA, blocked with 10% serum, and incubated with NBP2-90707 antibody (1:60) at 4C overnight. Then cells were stained with the Alexa Fluor(R) 488-conjugated Goat Anti-rabbit IgG secondary antibody (green) and counterstained with DAPI (blue).](http://images.novusbio.com/fullsize/nbp2-90707_rabbit-monoclonal-ilt5-cd85a-lilrb3-antibody-058-23520251544338.png)
![Western Blot: ILT5/CD85a/LILRB3 Antibody [NBP2-15015] - Sample (30 ug of whole cell lysate) A: Jurkat 7.5% SDS PAGE diluted at 1:2000](http://images.novusbio.com/fullsize/ILT5-CD85a-LILRB3-Antibody-Western-Blot-NBP2-15015-img0002.jpg "Western Blot: ILT5/CD85a/LILRB3 Antibody [NBP2-15015] - Sample (30 ug of whole cell lysate) A: Jurkat 7.5% SDS PAGE diluted at 1:2000")